INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

MYGNMYRIAD GENETICS INC

CIK 0000899923

EDGAR filingsOpen in network
Disclosed transactions28
Buys / sells0 / 1
Max Insider Score21
Connections14with evidence

MYGN · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
FL
Fox Jennifer LynneChief Legal & Corp Strategy
MYGNMYRIAD GENETICS INC
Grant or award
A—
39.4K sh
Nov 1, 2026Nov 2, 2026
traded Nov 1, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2835 · In Vitro & In Vivo Diagnostic Substances · Nov 4, 2026
  • ← Insider ofevidence
    Sikri VishalEVP, Commercial · Sep 17, 2026
  • ← Insider ofevidence
    Fox Jennifer LynneChief Legal Officer · Sep 8, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F
$10K
2,555 sh
Sep 21, 2026
Sep 22, 2026
traded Sep 21, 2026
+1d
SEC FORM 4

Evidence

21
SV
Sikri VishalEVP, Commercial
MYGNMYRIAD GENETICS INC
Grant or award
A—
257.7K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC FORM 4

Evidence

15
FL
Fox Jennifer LynneChief Legal Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$14K
4,398 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$27K
8,761 sh
Aug 16, 2026Aug 17, 2026
traded Aug 16, 2026
+1dSEC FORM 4

Evidence

9
DJ
Donnelly Brian JChief Commerical Officer
MYGNMYRIAD GENETICS INC
Grant or award
A$20K
5,000 sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC FORM 4

Evidence

12
KR
Kumar RashmiDirector
MYGNMYRIAD GENETICS INC
Open-market sale · 10b5-1 plan
SELL$67K
15.0K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC FORM 4

Evidence

21
DS
Davis Mark StevenDirector
MYGNMYRIAD GENETICS INC
Grant or award
A—
59.7K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC FORM 4

Evidence

9
JR
Jampa RajChief Technology Officer
MYGNMYRIAD GENETICS INC
Grant or award
A—
251.9K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC FORM 4

Evidence

19
DJ
Donnelly Brian JChief Commerical Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$269K
56.0K sh
May 1, 2026May 4, 2026
traded May 1, 2026
+3dSEC FORM 4

Evidence

9
VM
Verratti MarkChief Operating Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$5,249
1,069 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC FORM 4

Evidence

9
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$4,645
946 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC FORM 4

Evidence

9
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$9,247
2,019 sh
Mar 22, 2026Mar 23, 2026
traded Mar 22, 2026
+1dSEC FORM 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$2,514
549 sh
Mar 22, 2026Mar 23, 2026
traded Mar 22, 2026
+1dSEC FORM 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$2,731
586 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC FORM 4

Evidence

9
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$22K
4,783 sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC FORM 4

Evidence

21
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Grant or award
A—
173.2K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$4,087
877 sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC FORM 4

Evidence

21
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Grant or award
A—
206.2K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$10K
2,192 sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC FORM 4

Evidence

21
DJ
Donnelly Brian JChief Commerical Officer
MYGNMYRIAD GENETICS INC
Grant or award
A—
226.8K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

12
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$60K
12.8K sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC FORM 4

Evidence

9
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$39K
8,288 sh
Mar 14, 2026Mar 16, 2026
traded Mar 14, 2026
+2dSEC FORM 4

Evidence

12
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$56K
11.9K sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC FORM 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$5,112
1,097 sh
Mar 14, 2026Mar 16, 2026
traded Mar 14, 2026
+2dSEC FORM 4

Evidence

13
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Grant or award
A—
4,994 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC FORM 4

Evidence

9
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$2,571
418 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC FORM 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$138
21 sh
Dec 25, 2025Dec 29, 2025
traded Dec 25, 2025
+4dSEC FORM 4

Evidence

  • ← Lobbied forevidence
    GUIDE CONSULTING SERVICES, INC.LDA 2T 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    BLOUNT STRATEGIC INITIATIVESLDA Q1 2026 first quarter · VET · Aug 26, 2026
  • ← Lobbied forevidence
    TIBER CREEK GROUPLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Kumar RashmiDirector · Jun 9, 2026
  • ← Insider ofevidence
    Davis Mark StevenDirector · Jun 5, 2026
  • ← Insider ofevidence
    Jampa RajChief Technology Officer · Jun 2, 2026
  • ← Insider ofevidence
    Verratti MarkChief Operating Officer · Apr 15, 2026
  • ← Insider ofevidence
    Donnelly Brian JChief Commerical Officer · Mar 16, 2026
  • ← Insider ofevidence
    Muzzey DaleChief Scientific Officer · Jan 2, 2026
  • ← Insider ofevidence
    Wheeler Benjamin RichardChief Financial Officer · Dec 29, 2025

    • Lobbying

    $380K reported · de-duplicated
    2026 Q2 $120K via firms2026 Q1 $260K in-house
    • In-house report$260K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • GUIDE CONSULTING SERVICES, INC.$30K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • BLOUNT STRATEGIC INITIATIVES$10K2026 Q1 · posted Aug 26, 2026 · VET
    • TODD STRATEGY GROUP$40K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • BLOUNT STRATEGIC INITIATIVES$10K2026 Q2 · posted Aug 26, 2026 · VET
    • TODD STRATEGY GROUP$40K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • In-house report—2026 Q2 · posted Aug 26, 2026 ·
    • GUIDE CONSULTING SERVICES, INC.$30K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • TIBER CREEK GROUP$40K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • TIBER CREEK GROUP$40K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.